Human IGF2BP3 ELISA kits are used to detect Insulin Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3) in serum, plasma, tissue homogenates, cell lysates and other biological samples. IGF2BP3, also called IMP3, is an RNA-binding protein that is abundant during embryonic development and is re-expressed in many cancers. It binds target transcripts and recruits them to cytoplasmic ribonucleoprotein complexes, which supports mRNA transport and storage, modulates translation and protects messages from endonuclease attack or microRNA-mediated decay. It preferentially recognises m6A-modified mRNAs and increases their stability, including those of MYC and CD44, thereby promoting cell adhesion, invadopodia formation and invasion in cancer cells. It also binds the 5'-UTR of IGF2 mRNAs. Elevated IGF2BP3 has been associated with poor prognosis in several tumours, so it is studied as a cancer biomarker.
Human IGF2BP3 (Insulin Like Growth Factor 2 mRNA Binding Protein 3) ELISA (Small Sample Volume)
SKU:
AEKE09754
Size:
96 Assays
Reactivity:
Human
Synonyms:
MP-3, IMP3, KOC1, VICKZ3, CT98, IGF II mRNA Binding Protein 3, Cancer/Testis Antigen 98, KH domain-containing protein overexpressed in cancer
Detection Method:
Sandwich
Sensitivity:
0.068 ng/mL
Range:
0.16-10 ng/mL
Standard:
10 ng/mL
Assay Length:
3.5h
Sample Type:
Serum, Plasma, Tissue Homogenates, Cell Lysates And Other Biological Fluids
Kit Components:
Component
Quantity
Storage
48T
96T
Pre-Coated Microplate
6 strips x 8 wells
12 strips x 8 wells
4°C/-20°C
Standard (Lyophilized)
1 vial
2 vials
4°C/-20°C
Biotinylated Antibody (100×)
60 μL
120 μL
4°C/-20°C
Streptavidin-HRP (100×)
60 μL
120 μL
4°C/-20°C
Standard / Sample Diluent Buffer
10 mL
20 mL
4°C/-20°C
Biotinylated Antibody Diluent
6 mL
12 mL
4°C/-20°C
HRP Diluent
6 mL
12 mL
4°C/-20°C
Wash Buffer (25×)
10 mL
20 mL
4°C/-20°C
TMB Substrate Solution
6 mL
10 mL
4°C/-20°C (store in dark)
Stop Reagent
3 mL
6 mL
4°C/-20°C
Plate Covers
1 piece
2 pieces
RT
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human IGF2BP3. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human IGF2BP3. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human IGF2BP3, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human IGF2BP3 in the samples is then determined by comparing the OD of the samples to the standard curve.
Standard Curve:
Concentration (ng/mL)
OD
Corrected OD
10.00
2.072
1.980
5.00
1.599
1.507
2.50
1.237
1.145
1.25
0.767
0.675
0.63
0.579
0.487
0.31
0.321
0.229
0.16
0.185
0.093
0.00
0.092
0.000
Linearity:
Matrix
1:2
1:4
1:8
1:16
Serum (n=5)
81-112%
87-103%
95-110%
87-103%
EDTA Plasma (n=5)
86-111%
94-104%
81-105%
92-109%
Heparin Plasma (n=5)
86-113%
80-104%
93-115%
90-116%
Recovery:
Matrix
Recovery range
Average
Serum (n=5)
80-96%
88%
EDTA Plasma (n=5)
94-100%
97%
Heparin Plasma (n=5)
84-105%
95%
Precision:
Intra-assay Precision (Precision within an assay)
Intra-assay Precision (Precision within an assay)：CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays)
Inter-assay Precision (Precision between assays)：CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
*Note: The below protocol is a sample protocol. Protocols are specific to each batch/lot. For the correct instructions please follow the protocol included in your kit.
Step
Protocol
1.
After the kit is equilibrated at room temperature, add 25 µL of Standard Working Buffer (gradually diluted according to the instructions) or 25 µL of sample to each well, and incubate at 37°C for 80 minutes.
2.
Discard the liquid in the plate, add 200 µL 1× Wash Buffer to each well, and wash the plate 3 times. After pat it dry against clean absorbent paper, add 100 µL Biotinylated Antibody Working Solution (1×) to each well, incubate at 37°C for 50 minutes.
3.
Discard the liquid in the plate, add 200 µL 1× Wash Buffer to each well, and wash the plate 3 times. After pat it dry against clean absorbent paper, add 100 µL 1× Streptavidin-HRP Working Solution to each well, incubate at 37°C for 50 minutes.
4.
Discard the liquid in the plate, add 200 µL 1× Wash Buffer to each well, and wash the plate 5 times. After pat it dry against clean absorbent paper, add 90 µL TMB Substrate Solution to each well, incubate at 37°C for 20 minutes in the dark.
5.
Add 50 µL Stop Solution to each well, shake plate on a plate shaker for 1 minute to mix. Record the OD at 450 nm immediately, calculation of the results.
When carrying out an ELISA assay it is important to prepare your samples in order to achieve the best possible results. Below we have a list of procedures for the preparation of samples for different sample types.
Sample Type
Protocol
Serum
Samples should be collected into a serum separator tube. After clotting for 2 hours at room temperature or overnight at 4°C, and then centrifuging at 1000 × g for 20 minutes. Assay freshly prepared serum immediately or store samples in aliquot at -20°C or -80°C for later use. Avoid repeated freeze-thaw cycles.
Plasma
Collect plasma using EDTA or heparin as an anticoagulant. Centrifuge samples at 1000 × g and 2-8°C for 15 minutes within 30 minutes of collection. Remove plasma and assay immediately or store samples in aliquot at -20°C or -80°C for later use. Avoid repeated freeze-thaw cycles.
Tissue homogenates
1. Rinse the tissues in pre-cooled PBS to completely remove excess blood, and weigh them before homogenization. 2. Mince the tissues and homogenize in fresh lysis buffer (PBS for most tissues). Use a glass homogenizer on ice. 3. Ultrasound the suspension until the solution is clear. 4. Centrifuge for 5 minutes at 10000 × g, collect the supernatant and assay immediately or store at ≤ -20°C.
Cell lysates
1. Wash adherent cells with PBS, detach with trypsin, and centrifuge at 1000 × g for 5 minutes. 2. Wash cells 3 times in PBS. 3. Resuspend cells in fresh lysis buffer at 107 cells/mL. Ultrasound if necessary. 4. Centrifuge at 1500 × g for 10 minutes at 2-8°C to remove debris. Assay immediately or store at ≤ -20°C.
Urine
Collect mid-stream first urine of the day directly into a sterile container. Centrifuge to remove particulate matter. Assay immediately or aliquot and store at ≤ -20°C. Avoid repeated freeze-thaw cycles.
Saliva
Collect saliva using a collection device. Centrifuge at 1000 × g for 15 minutes at 2-8°C. Remove particulates and assay immediately or aliquot and store at ≤ -20°C. Avoid repeated freeze-thaw cycles.
Feces
Dry feces weighing more than 50 mg were collected. Wash with PBS (w:v = 1:9). Sonicate and centrifuge at 5000 × g for 10 minutes. Collect the supernatant and assay immediately.
CSF (Cerebrospinal fluid)
Remove particulates by centrifugation. Assay immediately or aliquot and store at ≤ -20°C. Avoid repeated freeze-thaw cycles.
Cell culture supernatant
Centrifuge samples at 1000 × g for 20 minutes. Collect the supernatant and assay immediately or store at -20°C or -80°C. Avoid repeated freeze-thaw cycles.
